Actavis has purchased a 90% of Zhejiang Chiral Medicine Chemicals. The purchase of the Hangzhou-based API manufacturer is designed to help reduce costs.
In-Pharma technologist
Thursday 10 April 2008
Actavis buys in China
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment